title: Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland.
abstract: Sixty extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from rivers and lakes in Switzerland were screened for individual strains additionally exhibiting a reduced quinolone susceptibility phenotype. Totally, 42 such isolates were found and further characterized for their molecular (fluoro)quinolone resistance mechanisms. PCR and sequence analysis were performed to identify chromosomal mutations in the quinolone resistance-determining regions (QRDR) of gyrA, gyrB, parC and parE and to describe the occurrence of the following plasmid-mediated quinolone resistance genes: qepA, aac-6'-Ib-cr, qnrA, qnrB, qnrC, qnrD and qnrS. The contribution of efflux pumps to the resistance phenotype of selected strains was further determined by the broth microdilution method in the presence and absence of the efflux pump inhibitor phe-arg-β-naphthylamide (PAβN). Almost all strains, except two isolates, showed at least one mutation in the QRDR of gyrA. Ten strains showed only one mutation in gyrA, whereas thirty isolates exhibited up to four mutations in the QRDR of gyrA, parC and/or parE. No mutations were detected in gyrB. Most frequently the amino-acid substitution Ser83→Leu was detected in GyrA followed by Asp87→Asn in GyrA, Ser80→Ile in ParC, Glu84→Val in ParC and Ser458→Ala in ParE. Plasmid-mediated quinolone resistance mechanisms were found in twenty isolates bearing QnrS1 (4/20), AAC-6'-Ib-cr (15/20) and QepA (1/20) determinants, respectively. No qnrA, qnrB, qnrC and qnrD were found. In the presence of PAβN, the MICs of nalidixic acid were decreased 4- to 32-fold. (Fluoro) quinolone resistance is due to various mechanisms frequently associated with ESBL-production in E. coli from surface waters in Switzerland.
authors.affiliation: Institute for Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Zurich, Switzerland.
authors.forename: Katrin
authors.initials: K
authors.lastname: Zurfluh
authors.affiliation: Institute for Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Zurich, Switzerland.
authors.forename: Helga
authors.initials: H
authors.lastname: Abgottspon
authors.affiliation: Institute for Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Zurich, Switzerland.
authors.forename: Herbert
authors.initials: H
authors.lastname: Hächler
authors.affiliation: Institute for Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Zurich, Switzerland.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Nüesch-Inderbinen
authors.affiliation: Institute for Food Safety and Hygiene, Vetsuisse Faculty University of Zurich, Zurich, Switzerland.
authors.forename: Roger
authors.initials: R
authors.lastname: Stephan
mesh_terms: D019943:Amino Acid Substitution; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D027081:DNA Gyrase / Q000235:genetics / Q000378:metabolism; D027101:DNA Topoisomerase IV / Q000235:genetics / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology*; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D060106:Lakes / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D011804:Quinolines / Q000494:pharmacology*; D045483:Rivers / Q000382:microbiology; D013557:Switzerland; D014871:Water Microbiology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D011804:Quinolines; C037219:quinoline; D001618:beta-Lactamases; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase
references.citation: FEMS Microbiol Lett. 2010 Dec;313(1):10-9
references.pmid: 20883500
references.citation: Sci Total Environ. 2012 Jun 15;427-428:263-8
references.pmid: 22560746
references.citation: J Antimicrob Chemother. 2008 Nov;62(5):948-50
references.pmid: 18772162
references.citation: J Antimicrob Chemother. 2008 May;61(5):999-1002
references.pmid: 18296438
references.citation: J Antimicrob Chemother. 2007 Apr;59(4):804-5
references.pmid: 17284539
references.citation: Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6
references.pmid: 15942878
references.citation: Lancet. 1998 Mar 14;351(9105):797-9
references.pmid: 9519952
references.citation: J Antimicrob Chemother. 2013 Apr;68(4):758-65
references.pmid: 23221627
references.citation: Front Microbiol. 2012 Jan 26;3:18
references.pmid: 22303296
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):639-45
references.pmid: 19064896
references.citation: Antimicrob Agents Chemother. 2006 Apr;50(4):1178-82
references.pmid: 16569827
references.citation: J Antimicrob Chemother. 2003 Apr;51(4):1001-5
references.pmid: 12654733
references.citation: Antimicrob Agents Chemother. 1996 Apr;40(4):879-85
references.pmid: 8849244
references.citation: APMIS. 2003 Sep;111(9):857-66
references.pmid: 14510643
references.citation: J Antimicrob Chemother. 2003 May;51(5):1109-17
references.pmid: 12697644
references.citation: J Microbiol Methods. 2005 Dec;63(3):219-28
references.pmid: 15935499
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3354-60
references.pmid: 17548499
references.citation: Nat Med. 2006 Jan;12(1):83-8
references.pmid: 16369542
references.citation: Front Microbiol. 2012 Feb 02;3:24
references.pmid: 22347217
references.citation: Appl Environ Microbiol. 2011 Oct;77(20):7113-20
references.pmid: 21856834
references.citation: Antimicrob Agents Chemother. 2006 Nov;50(11):3953-5
references.pmid: 16954321
references.citation: Antimicrob Agents Chemother. 2005 Feb;49(2):801-3
references.pmid: 15673773
references.citation: J Antimicrob Chemother. 2004 Mar;53(3):544-5
references.pmid: 14762057
references.citation: J Antimicrob Chemother. 2008 Nov;62(5):1151-2
references.pmid: 18669519
references.citation: Antimicrob Agents Chemother. 1982 Jul;22(1):15-22
references.pmid: 6214994
references.citation: Antimicrob Agents Chemother. 2007 Jul;51(7):2650-1
references.pmid: 17452482
references.citation: Antimicrob Agents Chemother. 2006 Aug;50(8):2872-4
references.pmid: 16870791
references.citation: Emerg Infect Dis. 2008 Feb;14(2):195-200
references.pmid: 18258110
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):603-8
references.pmid: 19029321
references.citation: J Antimicrob Chemother. 2011 Mar;66(3):512-6
references.pmid: 21172781
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):1892-7
references.pmid: 19258263
references.citation: Antimicrob Agents Chemother. 1994 Oct;38(10):2477-9
references.pmid: 7840592
references.citation: Appl Environ Microbiol. 2013 May;79(9):3021-6
references.pmid: 23455339
references.citation: Clin Microbiol Rev. 2009 Oct;22(4):664-89
references.pmid: 19822894
references.citation: Antimicrob Agents Chemother. 2011 Mar;55(3):1266-9
references.pmid: 21173174
references.citation: Int J Antimicrob Agents. 2005 May;25(5):358-73
references.pmid: 15848289
references.citation: J Infect Chemother. 2011 Apr;17(2):149-82
references.pmid: 20886256
references.citation: Front Microbiol. 2013 May 24;4:125
references.pmid: 23745120
references.citation: Clin Infect Dis. 2013 Sep;57(5):704-10
references.pmid: 23723195
references.citation: Antimicrob Agents Chemother. 2009 Jun;53(6):2227-38
references.pmid: 19307361
references.citation: J Antimicrob Chemother. 2007 Aug;60(2):394-7
references.pmid: 17561500
references.citation: Chemosphere. 2012 Mar;87(1):37-42
references.pmid: 22182707
references.citation: Antimicrob Agents Chemother. 2001 Aug;45(8):2378-80
references.pmid: 11451702